Estimation of the maternal vitamin D intake that maintains circulating 25-hydroxyvitamin D in late gestation at a concentration sufficient to keep umbilical cord sera ≥25-30 nmol/L: a dose-response, double-blind, randomized placebo-controlled trial in pregnant women at northern latitude

Karen M O'Callaghan, Áine Hennessy, George L J Hull, Karina Healy, Christian Ritz, Louise C Kenny, Kevin D Cashman, Mairead E Kiely, Karen M O'Callaghan, Áine Hennessy, George L J Hull, Karina Healy, Christian Ritz, Louise C Kenny, Kevin D Cashman, Mairead E Kiely

Abstract

Background: In the absence of dose-response data, Dietary Reference Values for vitamin D in nonpregnant adults are extended to pregnancy.

Objective: The aim was to estimate vitamin D intake needed to maintain maternal 25-hydroxyvitamin D [25(OH)D] in late gestation at a concentration sufficient to prevent newborn 25(OH)D <25-30 nmol/L, a threshold indicative of increased risk of nutritional rickets.

Design: We conducted a 3-arm, dose-response, double-blind, randomized placebo-controlled trial in Cork, Ireland (51.9oN). A total of 144 white-skinned pregnant women were assigned to receive 0, 10 (400 IU), or 20 (800 IU) µg vitamin D3/d from ≤18 wk of gestation. Vitamin D metabolites at 14, 24, and 36 wk of gestation and in cord sera, including 25(OH)D3, 3-epi-25(OH)D3, 24,25(OH)2D3, and 25(OH)D2 were quantified by liquid chromatography-tandem mass spectrometry. A curvilinear regression model predicted the total vitamin D intake (from diet and antenatal supplements plus treatment dose) that maintained maternal 25(OH)D in late gestation at a concentration sufficient to maintain cord 25(OH)D at ≥25-30 nmol/L.

Results: Mean ± SD baseline 25(OH)D was 54.9 ± 10.7 nmol/L. Total vitamin D intakes at the study endpoint (36 wk of gestation) were 12.1 ± 8.0, 21.9 ± 5.3, and 33.7 ± 5.1 µg/d in the placebo and 10-µg and 20-µg vitamin D3 groups, respectively; and 25(OH)D was 24.3 ± 5.8 and 29.2 ± 5.6 nmol/L higher in the 10- and 20-µg groups, respectively, compared with placebo (P < 0.001). For maternal 25(OH)D concentrations ≥50 nmol/L, 95% of cord sera were ≥30 nmol/L and 99% were >25 nmol/L. The estimated vitamin D intake required to maintain serum 25(OH)D at ≥50 nmol/L in 97.5% of women was 28.9 µg/d.

Conclusions: Thirty micrograms of vitamin D per day safely maintained serum 25(OH)D concentrations at ≥50 nmol/L in almost all white-skinned women during pregnancy at a northern latitude, which kept 25(OH)D at >25 nmol/L in 99% and ≥30 nmol/L in 95% of umbilical cord sera. This trial was registered at www.clinicaltrials.gov as NCT02506439.

Figures

FIGURE 1
FIGURE 1
CONSORT flow diagram of participant enrollment, random assignment, and biochemical analysis throughout the study by treatment group, where n is based on the total number of samples available for each visit. Any participant who did not provide a blood sample at baseline was included in the descriptive and biochemical analysis at later time points but excluded from the dose-response analysis, whereas women missing a midpoint sample only were included in both the dose-response analysis and the analysis at endpoint, if a blood sample was collected at this time point. The numbers of women who provided both a baseline and ≥1 follow-up sample (midpoint or endpoint) were 43, 42, and 43 for the placebo and 10- and 20-µg groups, respectively, which left a final number of 128 for the dose-response analysis. CONSORT, Consolidated Standards of Reporting Trials; inclu., including.
FIGURE 2
FIGURE 2
Mean maternal serum 25(OH)D concentrations achieved at each time point by intervention group. n = 40, 35, and 43 for the placebo and 10- and 20-µg groups, respectively, in which the analysis includes women who provided a blood sample at all 3 time points. Total mean ± SD vitamin D intakes (including habitual diet and supplementation plus treatment dose) were 12.1 ± 8.0, 21.9 ± 5.3, and 33.7 ± 5.1 µg/d in the placebo and 10- and 20-µg groups, respectively. Mean gestational age = 14, 24, and 36 wk at baseline, midpoint, and endpoint, respectively. Differences in mean serum 25(OH)D within groups from baseline to endpoint were all significantly different (P < 0.01 in all cases, paired-samples t test for each group). 25(OH)D, 25-hydroxyvitamin D.
FIGURE 3
FIGURE 3
The relation between achieved serum 25(OH)D concentrations and total vitamin D intake in pregnant women living at 51.9°N, assessed by using a curvilinear regression model. The mean response is indicated by the central line, and the outer lines are its 95% prediction intervals; n = 128. Horizontal lines represent serum 25(OH)D thresholds of 25, 30, and 50 nmol/L, respectively. 25(OH)D, 25-hydroxyvitamin D.
FIGURE 4
FIGURE 4
Association of maternal 25(OH)D at 36 wk of gestation and umbilical cord 25(OH)D concentrations (linear trendline: y = 0.4391x + 5.6922; R² = 0.62; n = 96; r = 0.79, P < 0.001) (A). The vertical line represents maternal 25(OH)D at 50 nmol/L, and the horizontal lines represent cord 25(OH)D at 25 and 30 nmol/L. When maternal 25(OH)D concentration was ≥50 nmol/L, cord concentrations were ≥25 nmol/L in all but 1 and ≥30 nmol/L in 95% of newborns. Association of maternal 24,25(OH)2D3 at 36 wk of gestation and umbilical cord 24,25(OH)2D3 (power fit trendline: y = 0.9715x0.6905; R² = 0.68; n = 95; r = 0.80, P < 0.001) (B). Association of the ratio of maternal 25(OH)D3 to 24,25(OH)2D3 at 36 wk of gestation and the ratio of umbilical cord 25(OH)D3 to 24,25(OH)2D3 (power fit trendline: y = 2.9938x0.5346; R² = 0.33; n = 95; r = 0.55, P < 0.001) (C). 25(OH)D, 25-hydroxyvitamin D; 25(OH)D3, 25-hydroxyvitamin D3; 24,25(OH)2D3, 24,25-dihydroxyvitamin D3.
FIGURE 5
FIGURE 5
Association of maternal 25(OH)D3 and 24,25(OH)2D3 concentrations at 36 wk of gestation (power fit trendline: y = 0.0162x1.3309; R² = 0.80; n = 121; r = 0.86, P < 0.001) (A); association of maternal 25(OH)D3 concentrations and the ratio of 25(OH)D3 to 24,25(OH)2D3 at 36 wk of gestation (power fit trendline: y = 61.575x−0.331; R² = 0.20; n = 121; r = –0.48, P < 0.001) (B). 25(OH)D3, 25-hydroxyvitamin D3; 24,25(OH)2D3, 24,25-dihydroxyvitamin D3.
FIGURE 6
FIGURE 6
Association of umbilical cord 25(OH)D3 and 24,25(OH)2D3 concentrations (power fit trendline: y = 0.0794x1.0036; R² = 0.71; n = 95; r = 0.82, P < 0.001) (A); association of the ratio of umbilical cord 25(OH)D3 concentrations and the ratio of 25(OH)D3 to 24,25(OH)2D3 (linear trendline: y = –0.0353x + 14.473; R² = 0.02; n = 95; r = –0.14, P = 0.173) (B). 25(OH)D3, 25-hydroxycholecalciferol; 24,25(OH)2D3, 24,25-dihydroxycholecalciferol.
FIGURE 7
FIGURE 7
Association of maternal vitamin D intake and 24,25(OH)2D3 concentrations (power fit trendline: y = 1.604x0.4247; R² = 0.20; n = 121; r = 0.401, P < 0.001) (A); association of maternal vitamin D intake and the ratio of 25(OH)D3 to 24,25(OH)2D3 at 36 wk of gestation (power fit trendline: y = 21.431x−0.135; R² = 0.08; n = 121; r = −0.26, P = 0.004) (B). 25(OH)D3, 25-hydroxycholecalciferol; 24,25(OH)2D3, 24,25-dihydroxycholecalciferol.

References

    1. Institute of Medicine Dietary Reference Intakes for calcium and vitamin D. Washington (DC): National Academies Press; 2011.
    1. Nordic Council of Ministers Nordic Nutrition Recommendations 2012: integrating nutrition and physical activity. Copenhagen (Denmark): Nordic Council of Ministers; 2012.
    1. Scientific Advisory Committee on Nutrition Vitamin D and health. London: The Stationary Office; 2016.
    1. European Food Safety Authority Scientific opinion on Dietary Reference Values for vitamin D. Parma (Italy): European Food Safety Authority; 2016.
    1. Kiely ME, Hemmingway A, O’ Callaghan KM. Vitamin D in pregnancy—current perspectives and future directions. Ther Adv Musculoskelet Dis 2017;9:145–54.
    1. Saraf R, Morton SM, Camargo CA Jr., Grant CC. Global summary of maternal and newborn vitamin D status—a systematic review. Matern Child Nutr 2016;12:647–68.
    1. Brannon PM, Picciano MF. Vitamin D in pregnancy and lactation in humans. Annu Rev Nutr 2011;31:89–115.
    1. Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D, Mughal MZ, Mäkitie O et al. .. Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab 2016;101:394–415.
    1. Kiely ME, O'Donovan SM, Kenny LC, Hourihane JOB, Irvine AD, Murray DM. Vitamin D metabolite concentrations in umbilical cord blood serum and associations with clinical characteristics in a large prospective mother-infant cohort in Ireland. J Steroid Biochem Mol Biol 2016;167:162–8.
    1. Hollis BW, Pittard WB. Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences. J Clin Endocrinol Metab 1984;59:652–7.
    1. Við Streym S, Kristine Moller U, Rejnmark L, Heickendorff L, Mosekilde L, Vestergaard P. Maternal and infant vitamin D status during the first 9 months of infant life—a cohort study. Eur J Clin Nutr 2013;67:1022–8.
    1. Grant CC, Stewart AW, Scragg R, Milne T, Rowden J, Ekeroma A, Wall C, Mitchell EA, Crengle S, Trenholme A et al. .. Vitamin D during pregnancy and infancy and infant serum 25-hydroxyvitamin D concentration. Pediatrics 2014;133:e143–53.
    1. March KM, Chen NN, Karakochuk CD, Shand AW, Innis SM, Von Dadelszen P, Barr SI, Lyon MR, Whiting SJ, Weiler HA et al. .. Maternal vitamin D3 supplementation at 50 mug/d protects against low serum 25-hydroxyvitamin D in infants at 8 wk of age: a randomized controlled trial of 3 doses of vitamin D beginning in gestation and continued in lactation. Am J Clin Nutr 2015;102:402–10.
    1. Cashman KD, Hill TR, Lucey AJ, Taylor N, Seamans KM, Muldowney S, Fitzgerald AP, Flynn A, Barnes MS, Horigan G et al. .. Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 2008;88:1535–42.
    1. Cashman KD, Wallace JM, Horigan G, Hill TR, Barnes MS, Lucey AJ, Bonham MP, Taylor N, Duffy EM, Seamans K et al. .. Estimation of the dietary requirement for vitamin D in free-living adults ≥ 64 y of age. Am J Clin Nutr 2009;89:1366–74.
    1. Mortensen C, Damsgaard CT, Hauger H, Ritz C, Lanham-New SA, Smith TJ, Hennessy Á, Dowling K, Cashman KD, Kiely M et al. .. Estimation of the dietary requirement for vitamin D in white children aged 4–8 y: a randomized, controlled, dose-response trial. Am J Clin Nutr 2016;104:1310–7.
    1. Smith TJ, Tripkovic L, Damsgaard CT, Mølgaard C, Ritz C, Wilson-Barnes SL, Dowling KG, Hennessy Á, Cashman KD, Kiely M et al. .. Estimation of the dietary requirement for vitamin D in adolescents aged 14–18 y: a dose-response, double-blind, randomized placebo-controlled trial. Am J Clin Nutr 2016;104:1301–9.
    1. Black LJ, Walton J, Flynn A, Cashman KD, Kiely M. Small increments in vitamin D intake by Irish adults over a decade show that strategic initiatives to fortify the food supply are needed. J Nutr 2015;145:969–76.
    1. Kiely M, Collins A, Lucey AJ, Andersen R, Cashman KD, Hennessy A. Development, validation and implementation of a quantitative food frequency questionnaire to assess habitual vitamin D intake. J Hum Nutr Diet 2016;29:495–504.
    1. Kiely ME, Zhang JY, Kinsella M, Khashan AS, Kenny LC. Vitamin D status is associated with uteroplacental dysfunction indicated by pre-eclampsia and small-for-gestational-age birth in a large prospective pregnancy cohort in Ireland with low vitamin D status. Am J Clin Nutr 2016;104:354–61.
    1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30.
    1. Goltzman D. Approach to hypercalcemia [updated 2016 Aug 8]. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M et al. ., editors. Endotext [Internet]. South Dartmouth (MA): , Inc.; 2000[cited 2017 Jul 20]. Available from: .
    1. R Development Core Team. A language and environment for statistical computing [Internet]. [cited 2017 Apr30]. Available from: .
    1. O'Neill CM, Kazantzidis A, Ryan MJ, Barber N, Sempos CT, Durazo-Arvizu RA, Jorde R, Grimnes G, Eiriksdottir G, Gudnason V et al. .. Seasonal changes in vitamin D-effective UVB availability in Europe and associations with population serum 25-hydroxyvitamin D. Nutrients 2016;8: 1–15.
    1. Cashman KD, Ritz C, Kiely ME; ODIN Collaborators. Improved dietary guidelines for vitamin D: application of individual participant data (IPD)-level meta-regression analyses. Nutrients 2017;9:469.
    1. Cooper C, Harvey NC, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Carr A, D'Angelo S et al. .. Maternal Gestational Vitamin D Supplementation and Offspring Bone Health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. Lancet Diabetes Endocrinol 2016;4:393–402.
    1. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011;26:2341–57.
    1. Dawodu A, Saadi HF, Bekdache G, Javed Y, Altaye M, Hollis BW. Randomized controlled trial (RCT) of vitamin D supplementation in pregnancy in a population with endemic vitamin D deficiency. J Clin Endocrinol Metab 2013;98:2337–46.
    1. Roth DE, Al Mahmud A, Raqib R, Akhtar E, Black RE, Baqui AH. Pharmacokinetics of high-dose weekly oral vitamin D3 supplementation during the third trimester of pregnancy in Dhaka, Bangladesh. Nutrients 2013;5:788–810.
    1. Wagner CL, McNeil R, Hamilton SA, Winkler J, Rodriguez Cook C, Warner G, Bivens B, Davis DJ, Smith PG, Murphy M et al. .. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am J Obstet Gynecol 2013;208:137.e1–13.
    1. Cashman KD, Hayes A, Galvin K, Merkel J, Jones G, Kaufmann M, Hoofnagle AN, Carter GD, Durazo-Arvizu RA, Sempos CT. Significance of serum 24,25-dihydroxyvitamin D in the assessment of vitamin D status: a double-edged sword? Clin Chem 2015;61:636–45.
    1. Hanson C, Anderson-Berry A, Lyden E, Kaufmann M, Wu A, Elliott E, Lee JI, Jones G. Dynamics of vitamin D metabolism in maternal-fetal dyads. J Pediatr Gastroenterol Nutr. 2016;62:486–90.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere